Literature DB >> 12843629

Discoordinate regulation of expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases-3 in bovine endometrial stromal cells on type-I collagen gel.

Michiko Hirata1, Takashi Sato, Michiko Tsumagari, Kazuyoshi Hashizume, Akira Ito.   

Abstract

To clarify the mechanism of extracellular matrix (ECM) remodeling in bovine endometrium, we investigated the regulation of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-3 (TIMP-3) in bovine endometrial stromal cells (BESCs) on type-I collagen gel. When BESCs were seeded onto the center of collagen gel placed in culture dishes, the cells proliferated and formed multiple cell layers after 2 weeks. Under this culture condition, the production of progelatinase B/promatrix metalloproteinase (proMMP)-9 was augmented, which was not occurred with monolayered BESCs on plastic dishes. The mRNA expression of progelatinase A/proMMP-2 was not changed, but proMMP-2 activation was augmented. Furthermore, the level of prostromelysin-1/proMMP-3 mRNA was decreased, whereas the gene expression of TIMP-3 tended to increase in BESCs cultured on collagen gel. When BESCs cultured on collagen gel were treated with transforming growth factor-beta1 (TGF-beta1), the levels of proMMP-9 in the medium and TIMP-3 mRNA were augmented, but the mRNA expression of proMMP-3 was further suppressed. However, the expression and activation of proMMP-2 were not changed by TGF-beta1 in BESCs cultured on either plastic or collagen-gel dishes. These results suggest that the expression of MMPs-2, 3 and 9 and TIMP-3 is likely to be discoordinately regulated due to interaction with collagen and/or TGF-beta1 in bovine endometrium, and thereby different sets of MMPs may be associated with ECM remodeling during implantation and placentation in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843629     DOI: 10.1248/bpb.26.1013

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  MiR-616-3p modulates cell proliferation and migration through targeting tissue factor pathway inhibitor 2 in preeclampsia.

Authors:  Yetao Xu; Dan Wu; Ziyan Jiang; Yuanyuan Zhang; Sailan Wang; Zhonghua Ma; Bingqing Hui; Jing Wang; Weiping Qian; Zhiping Ge; Lizhou Sun
Journal:  Cell Prolif       Date:  2018-07-20       Impact factor: 6.831

2.  Differential immunohistochemical expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in cow uteri with adenomyosis during follicular phase.

Authors:  Lio Moreira; Eulógio Carlos Queiroz de Carvalho; Maria Clara Caldas-Bussiere
Journal:  Vet Res Commun       Date:  2011-04-06       Impact factor: 2.459

3.  Prognostic significance of tissue factor pathway inhibitor-2 in pancreatic carcinoma and its effect on tumor invasion and metastasis.

Authors:  Zhigang Tang; Guangyong Geng; Qiang Huang; Geliang Xu; Hejie Hu; Jiong Chen; Jiansheng Li
Journal:  Med Oncol       Date:  2009-09-10       Impact factor: 3.064

4.  Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma.

Authors:  Lu-Lu Zhai; Chong-Yang Cai; Yang Wu; Zhi-Gang Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

5.  Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma.

Authors:  Lu-Lu Zhai; Yang Wu; Chong-Yang Cai; Zhi-Gang Tang
Journal:  Onco Targets Ther       Date:  2015-10-07       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.